Related Experiment Video

Updated: Feb 16, 2026

Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment
11:19

Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment

Published on: February 3, 2016

13.1K

KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma

Venugopal Vinod Prabhu1, S Niranjali Devaraj2

  • 1Department of Biochemistry, University of Madras, Guindy campus, Chennai-600025, Tamil Nadu, India.

Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer
|December 29, 2017
PubMed

Insights

Kang-Ai 1 (KAI1), also known as CD82, is a metastasis suppressor gene that inhibits non-small-cell lung carcinoma (NSCLC) spread. Its differential expression offers potential for novel NSCLC therapies targeting metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Lung cancer is a leading cause of cancer death, with non-small-cell lung carcinoma (NSCLC) accounting for 85% of cases.
  • Metastasis is a primary driver of mortality in NSCLC patients.
  • Kang-Ai 1 (KAI1), also known as CD82, is a tumor metastasis suppressor gene that inhibits cancer progression.

Purpose of the Study:

  • To review the differential expression of KAI1/CD82 in NSCLC.
  • To highlight KAI1/CD82's role as a metastasis suppressor.
  • To explore the therapeutic potential of targeting KAI1/CD82 in NSCLC treatment.

Main Methods:

  • Literature review focusing on KAI1/CD82 expression and function in NSCLC.
  • Analysis of KAI1/CD82's mechanisms in suppressing metastasis, including effects on cell motility, adhesion, and signaling pathways (EGFR, Wnt).

Main Results:

  • KAI1/CD82 exhibits differential expression in NSCLC, correlating with metastatic potential.
  • KAI1/CD82 suppresses metastasis through multiple cellular mechanisms.
  • KAI1/CD82 can attenuate EGFR and Wnt signaling pathways, crucial for metastatic colonization.

Conclusions:

  • KAI1/CD82 is a significant tumor metastasis suppressor in NSCLC.
  • The differential expression of KAI1/CD82 presents a promising target for novel NSCLC therapies.
  • Targeting KAI1/CD82 may reduce the metastatic potential of malignant tumors.

More Related Videos

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.9K
Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR08:56

Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR

Published on: January 29, 2016

10.4K

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.5K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
25.0K